Inventor · disambiguated record
Walter Boudewijn Leopold Wouters
Also filed as: WOUTERS WALTER B L · WOUTERS WALTER BOUDEWIJN LEOPO · WOUTERS WALTER BOUDEWIJN LEOPOLD
19 granted patents·2 pending applications·88 citations·filing 2003–2016
93Inventor score
Files withJANSSEN PHARMACEUTICA NV11MABIRE DOMINIQUE JEAN-PIERRE5KENNIS LUDO EDMOND JOSEPHINE2GUILLEMONT JEROME EMILE GEORGES1MEVELLEC LAURENCE ANNE1
Top patents by PatentIndex Score
21 records- 0187US8188103B2Substituted 2-alkyl quinazolinone derivatives as PARP inhibitorsVAN DER AA MARCEL JOZEF MARIA·Filed 2010·Granted May 29, 2012·14 cites·7 claims
- 0285US7928104B27-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitorsMABIRE DOMINIQUE JEAN-PIERRE·Filed 2004·Granted Apr 19, 2011·25 cites·12 claims
- 0385US7803795B2Phthalazine derivatives as parp inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Sep 28, 2010·7 cites·8 claims
- 0482US7652014B2Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Jan 26, 2010·17 cites·28 claims
- 0581US8623872B2Quinazolinone derivatives as PARP inhibitorsGUILLEMONT JEROME EMILE GEORGES·Filed 2005·Granted Jan 7, 2014·3 cites·17 claims
- 0680US7879857B26-substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Feb 1, 2011·11 cites·10 claims
- 0777US8946221B2Phthalazine derivatives as PARP inhibitorsMEVELLEC LAURENCE ANNE·Filed 2010·Granted Feb 3, 2015·5 cites·6 claims
- 0875US8080557B2Quinazolinedione derivatives as PARP inhibitorsKENNIS LUDO EDMOND JOSEPHINE·Filed 2005·Granted Dec 20, 2011·3 cites·18 claims
- 0974US9522905B2Quinazolinone derivatives as PARP inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Dec 20, 2016·1 cites·11 claims
- 1070US8623884B2Quinazolinedione derivatives as PARP inhibitorsKENNIS LUDO EDMOND JOSEPHINE·Filed 2011·Granted Jan 7, 2014·1 cites·9 claims
- 1162US10150757B2Quinazolinone derivatives as PARP inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Dec 11, 2018·0 cites·7 claims
- 1262US9255080B2Quinazolinedione derivatives as PARP inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Feb 9, 2016·0 cites·8 claims
- 1362US7214705B2Bafilomycin-like metabolite from a novel micromonospora speciesJANSSEN PHARMACEUTICA NV·Filed 2003·Granted May 8, 2007·1 cites·4 claims
- 1459US9115084B26-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Aug 25, 2015·0 cites·1 claims
- 1556US7803600B2Micromonospora species that produces a bafilomycin-like metaboliteJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 28, 2010·0 cites·2 claims
- 1655US8450486B26-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitorsMABIRE DOMINIQUE JEAN-PIERRE·Filed 2011·Granted May 28, 2013·0 cites·1 claims
- 1755US7855207B26-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Dec 21, 2010·0 cites·5 claims
- 1853US8071612B26-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitorsMABIRE DOMINIQUE JEAN-PIERRE·Filed 2010·Granted Dec 6, 2011·0 cites·5 claims
- 1953US2016108020A1Quinazolinedione derivatives as parp inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Application pending·0 cites
- 2046US8524714B27-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitorsMABIRE DOMINIQUE JEAN-PIERRE·Filed 2011·Granted Sep 3, 2013·0 cites·1 claims
- 2144US2011230491A16-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitorsMABIRE DOMINIQUE JEAN-PIERRE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Walter Boudewijn Leopold Wouters files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →